Application number | Title of the application | Filing Date | Status |
---|
Array
(
[id] => 1454737
[patent_doc_number] => 06462210
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-08
[patent_title] => 'Fractionation process for the unsaponifiable material derived from black-liquor soaps'
[patent_app_type] => B1
[patent_app_number] => 09/293282
[patent_app_country] => US
[patent_app_date] => 1999-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 9522
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/462/06462210.pdf
[firstpage_image] =>[orig_patent_app_number] => 09293282
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/293282 | Fractionation process for the unsaponifiable material derived from black-liquor soaps | Apr 15, 1999 | Issued |
Array
(
[id] => 4279863
[patent_doc_number] => 06281376
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-28
[patent_title] => 'Therapeutic compound--fatty acid conjugates'
[patent_app_type] => 1
[patent_app_number] => 9/289715
[patent_app_country] => US
[patent_app_date] => 1999-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19525
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/281/06281376.pdf
[firstpage_image] =>[orig_patent_app_number] => 289715
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/289715 | Therapeutic compound--fatty acid conjugates | Apr 11, 1999 | Issued |
Array
(
[id] => 1241374
[patent_doc_number] => 06683197
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-27
[patent_title] => 'Process for the production of 4,4-dimethyl-5-cholesta-8,14,24-trien-3-01 and intermediate products in process (I)'
[patent_app_type] => B1
[patent_app_number] => 09/288691
[patent_app_country] => US
[patent_app_date] => 1999-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6072
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/683/06683197.pdf
[firstpage_image] =>[orig_patent_app_number] => 09288691
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/288691 | Process for the production of 4,4-dimethyl-5-cholesta-8,14,24-trien-3-01 and intermediate products in process (I) | Apr 8, 1999 | Issued |
Array
(
[id] => 4174204
[patent_doc_number] => 06140518
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-31
[patent_title] => 'Steroid bisphosphonates'
[patent_app_type] => 1
[patent_app_number] => 9/147430
[patent_app_country] => US
[patent_app_date] => 1999-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6304
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/140/06140518.pdf
[firstpage_image] =>[orig_patent_app_number] => 147430
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/147430 | Steroid bisphosphonates | Apr 7, 1999 | Issued |
Array
(
[id] => 1312926
[patent_doc_number] => 06610676
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-08-26
[patent_title] => 'Nitrate esters of corticoid compounds and pharmaceutical applications thereof'
[patent_app_type] => B1
[patent_app_number] => 09/269729
[patent_app_country] => US
[patent_app_date] => 1999-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5150
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 505
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/610/06610676.pdf
[firstpage_image] =>[orig_patent_app_number] => 09269729
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/269729 | Nitrate esters of corticoid compounds and pharmaceutical applications thereof | Apr 1, 1999 | Issued |
Array
(
[id] => 4290772
[patent_doc_number] => 06268516
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Cationic amphiphilic lipids for liposomal gene transfer'
[patent_app_type] => 1
[patent_app_number] => 9/230842
[patent_app_country] => US
[patent_app_date] => 1999-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4523
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268516.pdf
[firstpage_image] =>[orig_patent_app_number] => 230842
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/230842 | Cationic amphiphilic lipids for liposomal gene transfer | Mar 29, 1999 | Issued |
Array
(
[id] => 1062928
[patent_doc_number] => 06849616
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-01
[patent_title] => 'Methods to potentiate intravenous estramustine phosphate'
[patent_app_type] => utility
[patent_app_number] => 09/276741
[patent_app_country] => US
[patent_app_date] => 1999-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5398
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/849/06849616.pdf
[firstpage_image] =>[orig_patent_app_number] => 09276741
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/276741 | Methods to potentiate intravenous estramustine phosphate | Mar 25, 1999 | Issued |
Array
(
[id] => 1570485
[patent_doc_number] => 06498153
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-24
[patent_title] => 'Extended release growth promoting two component composition'
[patent_app_type] => B1
[patent_app_number] => 09/273862
[patent_app_country] => US
[patent_app_date] => 1999-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5709
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 351
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/498/06498153.pdf
[firstpage_image] =>[orig_patent_app_number] => 09273862
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/273862 | Extended release growth promoting two component composition | Mar 21, 1999 | Issued |
Array
(
[id] => 7634690
[patent_doc_number] => 06656929
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-02
[patent_title] => 'Pharmaceutical composition with a synthetic natural progesterone and oestradiol base and its preparation process'
[patent_app_type] => B1
[patent_app_number] => 09/268353
[patent_app_country] => US
[patent_app_date] => 1999-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2524
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/656/06656929.pdf
[firstpage_image] =>[orig_patent_app_number] => 09268353
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/268353 | Pharmaceutical composition with a synthetic natural progesterone and oestradiol base and its preparation process | Mar 15, 1999 | Issued |
Array
(
[id] => 1396548
[patent_doc_number] => 06541463
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-01
[patent_title] => 'Inhibitors of type 5 and type 3 17-hydroxysteroid dehydrogenase and methods for their use'
[patent_app_type] => B1
[patent_app_number] => 09/265807
[patent_app_country] => US
[patent_app_date] => 1999-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 29
[patent_no_of_words] => 76305
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/541/06541463.pdf
[firstpage_image] =>[orig_patent_app_number] => 09265807
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/265807 | Inhibitors of type 5 and type 3 17-hydroxysteroid dehydrogenase and methods for their use | Mar 9, 1999 | Issued |
Array
(
[id] => 4248076
[patent_doc_number] => 06136800
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-24
[patent_title] => '17-Difluoromethylene-estratrienes'
[patent_app_type] => 1
[patent_app_number] => 9/263062
[patent_app_country] => US
[patent_app_date] => 1999-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 7322
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/136/06136800.pdf
[firstpage_image] =>[orig_patent_app_number] => 263062
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/263062 | 17-Difluoromethylene-estratrienes | Mar 7, 1999 | Issued |
09/254271 | INTERMEDIATES FOR THE SYNTHESIS OF VITAMIN D AND STEROID DERIVATIVES AND PROCESSES FOR PREPARATION THEREOF | Mar 2, 1999 | Abandoned |
09/242738 | PROCESS FOR THE PRODUCING ELTANOLONE | Feb 22, 1999 | Abandoned |
Array
(
[id] => 3946036
[patent_doc_number] => 05977096
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-02
[patent_title] => 'Steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances'
[patent_app_type] => 1
[patent_app_number] => 9/253650
[patent_app_country] => US
[patent_app_date] => 1999-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7673
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 251
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/977/05977096.pdf
[firstpage_image] =>[orig_patent_app_number] => 253650
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/253650 | Steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances | Feb 19, 1999 | Issued |
Array
(
[id] => 4349947
[patent_doc_number] => 06214814
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Use of betulinic acid derivatives for inhibiting cancer growth'
[patent_app_type] => 1
[patent_app_number] => 9/251309
[patent_app_country] => US
[patent_app_date] => 1999-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 4604
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214814.pdf
[firstpage_image] =>[orig_patent_app_number] => 251309
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/251309 | Use of betulinic acid derivatives for inhibiting cancer growth | Feb 16, 1999 | Issued |
09/249462 | ANDROSTANE STEROIDS AS NEUROCHEMICAL INITIATORS OF CHANGE IN HUMAN HYPOTHALAMIC FUNCTION AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS | Feb 11, 1999 | Abandoned |
Array
(
[id] => 4296848
[patent_doc_number] => 06180780
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-30
[patent_title] => 'Processes for preparation of 9,11-epoxy steroids and intermediates useful therein'
[patent_app_type] => 1
[patent_app_number] => 9/246908
[patent_app_country] => US
[patent_app_date] => 1999-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 48101
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/180/06180780.pdf
[firstpage_image] =>[orig_patent_app_number] => 246908
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/246908 | Processes for preparation of 9,11-epoxy steroids and intermediates useful therein | Feb 8, 1999 | Issued |
Array
(
[id] => 4324384
[patent_doc_number] => 06331622
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-18
[patent_title] => 'Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein'
[patent_app_type] => 1
[patent_app_number] => 9/246204
[patent_app_country] => US
[patent_app_date] => 1999-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 48079
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/331/06331622.pdf
[firstpage_image] =>[orig_patent_app_number] => 246204
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/246204 | Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein | Feb 7, 1999 | Issued |
Array
(
[id] => 1560956
[patent_doc_number] => 06437156
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-20
[patent_title] => '19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function'
[patent_app_type] => B1
[patent_app_number] => 09/241594
[patent_app_country] => US
[patent_app_date] => 1999-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7401
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 767
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/437/06437156.pdf
[firstpage_image] =>[orig_patent_app_number] => 09241594
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/241594 | 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function | Feb 1, 1999 | Issued |
Array
(
[id] => 4370719
[patent_doc_number] => 06288050
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-09-11
[patent_title] => 'Steroid sulfatase inhibitors and methods for making and using the same'
[patent_app_type] => 1
[patent_app_number] => 9/236842
[patent_app_country] => US
[patent_app_date] => 1999-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6949
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/288/06288050.pdf
[firstpage_image] =>[orig_patent_app_number] => 236842
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/236842 | Steroid sulfatase inhibitors and methods for making and using the same | Jan 24, 1999 | Issued |